Gsk (GSK) Return on Sales (2009 - 2026)
Gsk (GSK) posted quarterly Return on Sales of 0.0% for Q2 2026, little changed year-over-year from 0.0% in Q2 2025, and down 94.26% quarter-over-quarter from 0.0% in Q1 2026.
Gsk (GSK) Return on Sales (2009 - 2026) Analysis & Trends
Gsk's Return on Sales history runs 18 years deep, the most recent figure standing at 0.0% for Q2 2026.
- In Q2 2026, Return on Sales changed 0.0% year-over-year to 0.0%; the TTM figure through Jun 2026 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed N/A from the prior year.
- Return on Sales for Q2 2026 stood at 0.0%, down from 0.0% in the prior quarter.
- The five-year high for Return on Sales was 0.01% in Q3 2022, with the low at 0.0% in Q3 2024.
- The 5-year median for Return on Sales is 0.0% (2023), against an average of 0.0%.
- The sharpest annual moves came in 2022 and 2023: Return on Sales rose 1 bps in 2022, then decreased 1 bps in 2023.
- Gsk's Return on Sales stood at 0.01% in 2022, then plunged by 57 bps to 0.0% in 2023, then sank by 33 bps to 0.0% in 2024, then soared by 49 bps to 0.0% in 2025, then sank by 94 bps to 0.0% in 2026.
- Business Quant data shows GSK's Return on Sales at 0.0% in Q2 2026, 0.0% in Q1 2026, and 0.0% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.32 Bn | 632.56 Bn | 17.26 Bn | 0.00% |
| 2 | AbbVie | 470.11 Bn | 463.54 Bn | 12.70 Bn | 0.00% |
| 3 | Merck | 376.14 Bn | 369.00 Bn | 12.21 Bn | 0.00% |
| 4 | Novartis Ag | 303.26 Bn | 295.57 Bn | 11.24 Bn | 0.00% |
| 5 | Astrazeneca | 257.39 Bn | 252.49 Bn | 12.86 Bn | 0.00% |
| 6 | Amgen | 236.59 Bn | 222.60 Bn | 7.24 Bn | 0.00% |
| 7 | Gilead Sciences | 181.91 Bn | 178.73 Bn | 6.22 Bn | -0.01% |
| 8 | Pfizer | 159.26 Bn | 147.57 Bn | 10.94 Bn | 0.00% |
| 9 | Gsk | 106.16 Bn | 101.99 Bn | 8.24 Bn | 0.00% |
| 10 | Sanofi | 55.11 Bn | 47.73 Bn | 10.79 Bn | 0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00% |
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.01% |
| Sep 30, 2022 | 0.01% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |